دورية أكاديمية

Insights into Clinical Disorders in Cowden Syndrome: A Comprehensive Review.

التفاصيل البيبلوغرافية
العنوان: Insights into Clinical Disorders in Cowden Syndrome: A Comprehensive Review.
المؤلفون: Pîrlog LM; Department of Molecular Sciences, Faculty of Medicine, University of Medicine and Pharmacy 'Iuliu Hațieganu', 400012 Cluj-Napoca, Romania., Pătrășcanu AA; Department of Molecular Sciences, Faculty of Medicine, University of Medicine and Pharmacy 'Iuliu Hațieganu', 400012 Cluj-Napoca, Romania., Militaru MS; Department of Molecular Sciences, Faculty of Medicine, University of Medicine and Pharmacy 'Iuliu Hațieganu', 400012 Cluj-Napoca, Romania.; Regional Laboratory Cluj-Napoca, Department of Medical Genetics, Regina Maria Health Network, 400363 Cluj-Napoca, Romania., Cătană A; Department of Molecular Sciences, Faculty of Medicine, University of Medicine and Pharmacy 'Iuliu Hațieganu', 400012 Cluj-Napoca, Romania.; Regional Laboratory Cluj-Napoca, Department of Medical Genetics, Regina Maria Health Network, 400363 Cluj-Napoca, Romania.; Department of Oncogenetics, 'Prof. Dr. I. Chiricuță' Institute of Oncology, 400015 Cluj-Napoca, Romania.
المصدر: Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2024 May 06; Vol. 60 (5). Date of Electronic Publication: 2024 May 06.
نوع المنشور: Journal Article; Review
اللغة: English
بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 9425208 Publication Model: Electronic Cited Medium: Internet ISSN: 1648-9144 (Electronic) Linking ISSN: 1010660X NLM ISO Abbreviation: Medicina (Kaunas) Subsets: MEDLINE
أسماء مطبوعة: Publication: 2018- : Basel, Switzerland : MDPI
Original Publication: Kaunas : Lietuvos gydytojų sąjunga
مواضيع طبية MeSH: Hamartoma Syndrome, Multiple*/genetics , Hamartoma Syndrome, Multiple*/diagnosis , PTEN Phosphohydrolase*/genetics, Female ; Humans ; Proteus Syndrome/genetics ; Proteus Syndrome/diagnosis ; Male
مستخلص: PTEN Hamartoma Tumour Syndrome (PHTS) encompasses diverse clinical phenotypes, including Cowden syndrome (CS), Bannayan-Riley-Ruvalcaba syndrome (BRRS), Proteus syndrome (PS), and Proteus-like syndrome. This autosomal dominant genetic predisposition with high penetrance arises from heterozygous germline variants in the PTEN tumour suppressor gene, leading to dysregulation of the PI3K/AKT/mTOR signalling pathway, which promotes the overgrowth of multiple and heterogenous tissue types. Clinical presentations of CS range from benign and malignant disorders, affecting nearly every system within the human body. CS is the most diagnosed syndrome among the PHTS group, notwithstanding its weak incidence (1:200,000), for which it is considered rare, and its precise incidence remains unknown among other important factors. The literature is notably inconsistent in reporting the frequencies and occurrences of these disorders, adding an element of bias and uncertainty when looking back at the available research. In this review, we aimed to highlight the significant disparities found in various studies concerning CS and to review the clinical manifestations encountered in CS patients. Furthermore, we intended to emphasize the great significance of early diagnosis as patients will benefit from a longer lifespan while being unceasingly advised and supported by a multidisciplinary team.
Competing Interests: The authors declare no conflicts of interest.
References: Oral Surg Oral Med Oral Pathol Oral Radiol. 2014 Apr;117(4):e301-10. (PMID: 24560406)
Front Oncol. 2022 Sep 23;12:951976. (PMID: 36212468)
J Pediatr Gastroenterol Nutr. 2014 May;58(5):553-60. (PMID: 24345843)
Hum Mol Genet. 2020 Oct 20;29(R2):R150-R157. (PMID: 32568377)
Gastroenterology. 2012 May;142(5):1093-1096.e6. (PMID: 22266152)
Biophys Rev. 2013 Mar;5(1):29-39. (PMID: 28510178)
Medicine (Baltimore). 2005 Mar;84(2):129-136. (PMID: 15758842)
J Clin Invest. 2019 Feb 1;129(2):452-464. (PMID: 30614812)
Cell Death Dis. 2019 Jul 18;10(8):546. (PMID: 31320611)
No To Shinkei. 2003 Mar;55(3):251-5. (PMID: 12728507)
Mod Pathol. 2019 Dec;32(12):1814-1822. (PMID: 31273317)
J Med Genet. 2001 Mar;38(3):159-64. (PMID: 11238682)
Am J Med Genet C Semin Med Genet. 2014 Jun;166C(2):156-72. (PMID: 24888963)
Eur J Med Genet. 2022 Jul;65(7):104533. (PMID: 35640862)
Diagn Pathol. 2023 Apr 4;18(1):43. (PMID: 37016356)
J Allergy Clin Immunol. 2017 Feb;139(2):607-620.e15. (PMID: 27477328)
Obstet Gynecol. 2009 Aug;114(2 Pt 2):477-479. (PMID: 19622968)
World Neurosurg. 2019 Jul;127:319-325. (PMID: 30905649)
Clin Genet. 2021 Feb;99(2):219-225. (PMID: 33140411)
J Clin Endocrinol Metab. 2011 Dec;96(12):E2063-71. (PMID: 21956414)
Surg Pathol Clin. 2019 Dec;12(4):901-919. (PMID: 31672297)
Cold Spring Harb Perspect Med. 2020 Apr 1;10(4):. (PMID: 31570378)
Front Med (Lausanne). 2021 Jun 10;8:658842. (PMID: 34179044)
Medicine (Baltimore). 2023 Jan 6;102(1):e32572. (PMID: 36607858)
J Oral Pathol Med. 2017 Sep;46(8):637-643. (PMID: 27889943)
J Med Genet. 2007 Sep;44(9):594-602. (PMID: 17526801)
Int J Dermatol. 1984 Sep;23(7):466-7. (PMID: 6490291)
J Med Genet. 2013 Apr;50(4):255-63. (PMID: 23335809)
Clin Cancer Res. 2012 Jan 15;18(2):400-7. (PMID: 22252256)
Pediatr Blood Cancer. 2016 Mar;63(3):544-6. (PMID: 26468640)
Cold Spring Harb Perspect Med. 2020 May 1;10(5):. (PMID: 31615872)
Genes Cancer. 2010 Dec;1(12):1170-7. (PMID: 21779440)
N Engl J Med. 2012 Sep 13;367(11):1002-11. (PMID: 22970944)
Cancers (Basel). 2019 Jun 18;11(6):. (PMID: 31216739)
J Biol Chem. 2003 Oct 3;278(40):38884-91. (PMID: 12847108)
Ital J Pediatr. 2021 Mar 30;47(1):80. (PMID: 33785023)
Int J Oncol. 2002 Sep;21(3):469-75. (PMID: 12168088)
J Neurol Surg A Cent Eur Neurosurg. 2019 Mar;80(2):134-137. (PMID: 30517962)
J Med Genet. 2005 Aug;42(8):e50. (PMID: 16061556)
Cancer Med. 2023 Jun;12(12):13701-13711. (PMID: 37132195)
Clin Imaging. 2020 Apr;60(2):180-185. (PMID: 31927175)
World Neurosurg. 2020 Jul;139:567-576. (PMID: 32344142)
Cancers (Basel). 2019 Jul 30;11(8):. (PMID: 31366089)
J Radiol Case Rep. 2020 Mar 31;14(3):1-6. (PMID: 33082915)
J Genet Couns. 2009 Feb;18(1):13-27. (PMID: 18972196)
Ann Dermatol. 2023 Apr;35(2):146-150. (PMID: 37041709)
Case Rep Pediatr. 2017;2017:9682803. (PMID: 28523199)
Head Neck Pathol. 2022 Mar;16(1):304-313. (PMID: 34106409)
J Oncol. 2020 Jul 14;2020:6384190. (PMID: 32733558)
Eur J Hum Genet. 2020 Oct;28(10):1387-1393. (PMID: 32533092)
Pahlavi Med J. 1976 Apr;7(2):262-9. (PMID: 1272600)
Histopathology. 2023 Jan;82(1):70-82. (PMID: 36468211)
Am J Med Genet B Neuropsychiatr Genet. 2007 Jun 5;144B(4):484-91. (PMID: 17427195)
Semin Oncol. 2001 Oct;28(5 Suppl 16):142-7. (PMID: 11706405)
J Med Genet. 2007 Sep;44(9):579-85. (PMID: 17526800)
J Dermatol Case Rep. 2011 Mar 26;5(1):8-13. (PMID: 21886759)
Annu Rev Med. 2020 Jan 27;71:103-116. (PMID: 31433956)
Am J Med Genet C Semin Med Genet. 2019 Dec;181(4):591-610. (PMID: 31609537)
Eur J Med Genet. 2020 May;63(5):103873. (PMID: 32058060)
Endocr Relat Cancer. 2018 Aug;25(8):T121-T140. (PMID: 29792313)
Mol Clin Oncol. 2020 Apr;12(4):329-335. (PMID: 32190315)
Cancers (Basel). 2021 Jun 22;13(13):. (PMID: 34206559)
J Thorac Imaging. 2018 Nov;33(6):W48-W50. (PMID: 30142139)
Am J Med Genet C Semin Med Genet. 2013 May;163C(2):122-30. (PMID: 23592320)
Transl Oncol. 2019 Feb;12(2):361-367. (PMID: 30504085)
J Med Genet. 2023 Jan;60(1):91-98. (PMID: 34937768)
Hum Mol Genet. 1998 Mar;7(3):507-15. (PMID: 9467011)
Onco Targets Ther. 2022 Apr 08;15:381-405. (PMID: 35422633)
Int J Mol Sci. 2022 Jan 29;23(3):. (PMID: 35163487)
Pathol Res Pract. 2021 Feb;218:153339. (PMID: 33482532)
Pediatr Dermatol. 2020 Sep;37(5):839-843. (PMID: 32657433)
J Med Genet. 2005 Apr;42(4):318-21. (PMID: 15805158)
Expert Rev Mol Med. 2004 Jan 30;6(3):1-18. (PMID: 14987415)
J Natl Cancer Inst. 2013 Nov 6;105(21):1607-16. (PMID: 24136893)
فهرسة مساهمة: Keywords: Cowden syndrome; PTEN; clinical disorders; review
المشرفين على المادة: EC 3.1.3.67 (PTEN Phosphohydrolase)
EC 3.1.3.67 (PTEN protein, human)
تواريخ الأحداث: Date Created: 20240525 Date Completed: 20240525 Latest Revision: 20240528
رمز التحديث: 20240528
مُعرف محوري في PubMed: PMC11123368
DOI: 10.3390/medicina60050767
PMID: 38792950
قاعدة البيانات: MEDLINE